Lung edema during sepsis is triggered by formation of gaps between endothelial cells followed by macrophage in¢ltration. Endothelial gap formation has been proposed to involve changes in the structure of the actin ¢lament cytoskeleton. Heat shock protein 27 (HSP27) is believed to modulate actin ¢lament dynamics or structure, in a manner dependent on its phosphorylation status. We hypothesized that HSP27 may play a role in endothelial gap formation, by a¡ecting actin dependent events in endothelial cells. As there has been no report concerning HSP27 in lung edema in vivo, we examined induction and phosphorylation of HSP27 in lung following LPS injection, as a model of sepsis. In lung, HSP27 mainly localized in capillary endothelial cells of the alveolus, and in smooth muscle cells of pulmonary arteries. HSP27 became signi¢cantly more phosphorylated at 3 h after LPS treatment, while the distribution of HSP27 remained unchanged. Pre-treatment with anti-TNFa antibody, which has been shown to reduce lung injury, blocked increases in HSP27 phosphorylation at 3 h. HSP27 phosphorylation was also increased in cultured rat pulmonary arterial endothelial cells (RPAEC) by treatment with TNFa, LPS, or H 2 O 2 . This phosphorylation was blocked by pretreatment with SB203580, an inhibitor of the upstream kinase, p38 MAP kinase. Increased endothelial permeability caused by H 2 O 2 in vitro was also blocked by SB203580. The amount of actin associated with HSP27 was reduced after treatment with LPS, or H 2 O 2 . In summary, HSP27 phosphorylation temporally correlated with LPS induced pathological endothelial cell gap formation in vivo and in a cell culture model system. This is the ¢rst report of increased HSP27 phosphorylation associated with pathological lung injury in an animal model of sepsis.
Introduction
Adult respiratory distress syndrome (ARDS) occurs in 18^25% of sepsis syndrome patients and results in up to 90% mortality. ARDS associated pulmonary edema, poorly compliant lungs, and refractory hypoxemia are due to impairment of endothelial barrier function and advancement of neutrophils through the endothelium into the tissues (reviewed in Martin and Silverman, 1992) .
The vascular endothelium is a semi-selective di¡usion barrier between the blood plasma and interstitial tissue. Inter-endothelial cell gap formation with loss of barrier function leads to neutrophil in¢ltration and tissue edema. Trans-endothelial permeability is increased by endothelial cell shape change and disruption of tight junctions between cells. It has been shown that reorganization of the actin-containing cytoskeleton is essential for shape changes and loss of tight junction integrity associated with increased permeability in endothelial cells (Alexander et al., 1988; Phillips et al., 1989; Shasby et al., 1982) .
HSP27 was identi¢ed as an inhibitor of actin polymerization when it was co-puri¢ed with vinculin from avian smooth muscle Miron et al., 1991) . Several reports indicate that HSP27 plays an important role in regulating the actincontaining cytoskeletal structure. HSP27 can inhibit actin polymerization in vitro (Miron et al., 1991) and this ability appears to be dependent on its phosphorylation status (Benndorf et al., 1994) . In cell lines transfected to overexpress HSP27, cortical actin arrays were increased as was pinocytotic activity (Lavoie et al., 1993a) . These increases were not observed in cell lines transfected with a mutant form of HSP27 incapable of being phosphorylated (Lavoie et al., 1993a) . Micro¢laments in cells transfected to over-express HSP27 were more stable to heat-shock treatment or cytochalasin D treatment (Lavoie et al., 1993b (Lavoie et al., , 1995 . Thus, HSP27 can a¡ect actin ¢lament structure by a mechanism that depends on the phosphorylation state of HSP27.
Phosphorylation of HSP27 is induced by a number of agents or treatments that cause edema. TNFa treatment, which causes lung edema in sheep (Horvath et al., 1988) , induced phosphorylation of HSP27 in endothelial cells (Arrigo, 1990; Robaye et al., 1989) . Thrombin, another agent capable of disrupting the barrier function of endothelial cells (Phillips et al., 1989) , induces HSP27 phosphorylation (Mendelsohn et al., 1991) . Treatment of cultured endothelial cells with hydrogen peroxide (H 2 O 2 ) caused increased endothelial cell monolayer permeability (Gilmont et al., 1996) and phosphorylation of HSP27 (Huot et al., 1997) . Furthermore, H 2 O 2 -induced endothelial micro¢lament fragmentation was blocked by an inhibitor of p38 mitogen activated protein (MAP) kinase, which is an upstream kinase involved in HSP27 phosphorylation (Huot et al., 1997) . These reports imply that HSP27 phosphorylation may be involved in loss of endothelial barrier function. Recently, p38 MAP kinase activation was reported to be a critical step in pertussis toxin-induced increased endothelial permeability, and phosphorylation of HSP27 was suggested as an e¡ecter of p38 MAP kinase (Garcia et al., 2002) . We examined expression or phosphorylation of HSP27 in the in vivo and in vitro models of sepsis-induced pulmonary edema.
Materials and methods

Sepsis model
Adult, male Sprague-Dawley rats (approximately 200 g) were used in these experiments. The sepsis group (18 rats) were given intraperitoneal injections of LPS (E. coli. serotype 0127:B8, Sigma, St Louis, MO, USA) 2 mg/kg from a 2 mg/ml stock solution in phosphate bu¡ered saline (PBS) and were euthanized in groups of three at 1, 3, 6, 12, 24 , and 48 h after injection. Control groups consisted of 3 rats without any treatment and 3 rats injected with 1 ml PBS/kg 12 h before euthanasia. The hearts and lungs were harvested, cooled immediately on dry ice and store in^808C prior to RNA isolation and protein analysis.
Immunohistochemistry
Rats (n = 3) were euthanized at each time-point after the treatment following exposure of the trachea under anesthesia. The lungs were initially ¢xed by in situ tracheal instillation with 4% formaldehyde in PBS. After removal, they were immersed in the same ¢xative at room temperature for 4 days. The left lobes were then cut horizontally and embedded in para¤n. Sections (4 mm thick) were prepared and stained with hematoxylin and eosin (H&E). Immunohistochemical stainings with rabbit anti-rodent HSP27 polyclonal antibody (1/ 500; Anti-HSP25, Stressgen Biotechnologies Corp., Victoria, BC, Canada) was performed using indirect reactions with a horseradish peroxidase (HRP) conjugated-secondary antibody.
Anti-TNFa neutralizing antibody treatment
Antibody group animals (9 rats) were pretreated with 1 ml of anti-TNFa neutralizing rabbit antisera ) 1 h before LPS injection. LPS only group (9 rats) were injected with normal rabbit serum. Treated and untreated rats were euthanized at 1, 3, and 12 h (n = 3) after LPS injection, and organs were harvested as described previously.
Plasma TNF level
Plasma was harvested from anti-TNFa antibody treated and normal rabbit serum treated rats at 1 or 3 h after LPS injection as well as from control untreated rats before the organs were harvested. TNFa levels were determined by bioassay utilizing the WEHI 164 sub clone 13 cell line and previously published methods . Samples were serially diluted in 96 well plates and WEHI cells in suspension (with actinomycin D) were added. The plates were allowed to incubate overnight at 378C followed by addition of MTT-Tetrazolium (Sigma). Plates were returned to the incubator for an additional 4 h followed by addition of acidi¢ed isopropanol overnight. Readings were performed at 550 nm with background subtraction at 630 nm. TNFa values were then extrapolated from a standard curve of human recombinant TNFa (Cetus Corporation, Emeryville, CA, USA) that was employed in the same assay.
Isolation of RNA
RNA was isolated from frozen tissues according to method of Chomczynski and Sacchi (Chomczynski and Sacchi, 1987) . Brie£y, samples were homogenized in a solution of 4 mol/ L guanidine isothiocynate, 25 mmol/L sodium citrate, 0.5% N-lauroyl sarcosine, and 0.1% mercaptoethanol with a polytron 3000 homogenizer (Brinkman Instruments Inc., Westbury, NY, USA). Total RNA was extracted with phenol-chloroform-isoamyl alcohol solution and precipitated with ethanol. Following a second ethanol precipitation, RNA was resuspended in water and quanti¢ed by spectrophotometric measurement.
Northern blot analysis of HSP27 mRNA RNA samples (20 mg) were denatured by incubation at 658C for 10 min in a bu¡er containing 20 mmol/L Hepes (PH 7.8), 1 mmol/L EDTA, 6% formaldehyde, and 50% formamide. RNA samples were separated by electrophoresis in 1.2% agarose gels containing 20 mmol/L Hepes, 1 mmol/L EDTA, and 6% formaldehyde and transferred onto nylon membranes (Biotrace HP; Gelman Sciences, Ann Arbor, MI, USA). After the blots were incubated for 2 h at 428C in solution containing 0.5% SDS, 400 mmol/L NaH 2 PO 4 (PH 7.2), 1 mmol/L EDTA, 1 mg/ml BSA, and 50% formamide, [
32 P]-labeled probes were added to the mixtures, which were then allowed to incubate for an additional 18 h. After hybridization, blots were washed twice in wash solution (16SSC, 0.1% SDS) at 428C, followed by high stringency washes in bu¡er containing 0.26SSC, 0.1% SDS twice at 658C for cDNA probes or at 558C for oligonucleotide probes. Radiolabeled probes for HSP27 were prepared from a full coding length cDNA (accession number M86389) by using [
32 P]-dCTP in a random primer reaction (Random primers DNA labeling system, Life Technologies Inc., Gaithersburg, MD, USA). Radiolabeled probes for 18s RNA were prepared with [ 32 P]-dATP by a tailing reaction using terminal deoxynucleotide transferase. The oligonucleot i d e s e q u e n c e 5 ' -A C G G T A T C T -GATCGTCTTCGAACC-3' was used to hybridize to 18s ribosomal RNA (Szyf et al., 1990) as a standard. RNAs were detected by autoradiography (Fuji RX ¢lms) following storage at^808C with intensifying screens. Relative quantities of HSP27 mRNA were determined by laser densitometry (Biorad GS-700 densitometer) and were normalized to 18s RNA.
Determination of phosphorylation status of HSP27
Frozen tissue samples were homogenized in an extraction bu¡er which contained 9 mol/L urea, 2% carrier ampholytes pH 3.0^10.0 (Bio-Rad), 2% CHAPS and 2% 2-mercaptoethanol. Protein concentration was determined using a modi¢ed Bradford assay (Louis and Lewis, 1985) . Isoelectric focusing (IEF) was carried out essentially described previously (Smoyer et al., 1996) using a model 111 Mini IEF cell (BioRad, Hercules, CA, USA). Brie£y, samples were loaded into the IEF gels contained 2% ampholine pH 3.0^10.0 (BioRad) and 6 mol/L urea. Isoelectric focusing was performed at 100 V for 15 min, 200 V for 15 min and 450 V for 90 min. Protein was transferred immediately after electrophoresis to polyvinylidene £uoride (PVDF) membranes (Millipore Corporation, Bedford, MA, USA) by semi-dry blotting apparatus (Pharmacia, Piscataway, NJ, USA). Membranes were blocked with 5% powdered milk in PBST and incubated with a monoclonal antibody directed against HSP27 (Bitar et al., 1991) for 2 h. Following washing, membranes were incubated with HRP-conjugated secondary antibody against mouse IgG (Jackson Immuno Research Laboratories Inc., West Grove, PA, USA) for 1 h. Detection was carried out by Western Blot Chemiluminescence Reagent Plus (NENTM Life Science Products, Boston, MA, USA). Band densities were determined using a Model GS-700 Imaging Densitometer. Multiple exposures were used to ensure that band densities fell within the linear range of the ¢lm. The density values (area6density) of mono-phosphorylated, di-phosphorylated and un-phosphorylated forms of HSP27 were determined for each sample. The phosphorylation status was calculated using the formula, (di-+ monophosphorylated)/unphosphorylated.
Determination of protein expression
Frozen tissue samples were homogenized in an extraction bu¡er which contained 10 mmol/L Tris-HCl, pH 7.4; 150 mmol/L NaCl; 1 mmol/ L EDTA; 0.1% SDS; 1% Triton X-100. Forty mg protein of each sample was separated by SDS PAGE followed by western blotting as described above. The blots were incubated with a polyclonal antibody directed against HSP27 were re-probed with a monoclonal antibody directed against all forms of actin (Sigma). Bands density values were determined using NIH image, and the density values of HSP27 were normalized to actin and reported as relative expression compared to non-treated samples.
Cell culture
Rat pulmonary arterial endothelial cells (RPAEC) (passage 10 to 16) were cultured in DMEM/F-12 medium (GibcoBRL, Grand Island, NY, USA) supplemented with 5% fetal calf serum (FCS), 50 m/ml penicillin and 50 m/ ml streptomycin (GibcoBRL) in a humidi¢ed incubator containing an atmosphere of 5% CO 2 and 95% air. RPAEC cultures were treated with 10 ng/ml LPS, 10 ng/ml TNFa, or various concentration of H 2 O 2 for 30 min before determining the phosphorylation status of HSP27, as described above. Some cells were pre-treated with an inhibitor of p38 MAP kinase, SB203580 (Calbiochem) (20 mmol/L) for 20 min prior to these treatments.
Endothelial cell permeability assay
Permeability assay was performed as described previously (Gilmont et al., 1996) , except that 70 kDa FITC-dextran (FD-70, Sigma) was used in this study. Brie£y, pulmonary endothelial cells were grown for 2 additional days after reaching con£uence on transparent 3-mmol/L pore, high pore density Falcon 25 mm ¢lter inserts in 6-well plates. Filter units were £oated with the aid of Styrofoam collar in 30 ml of Hank's balanced solution and overlaid with 2 ml Hank's solution containing 1 mg/ml FD-70. Aliquots (200 ml) were taken at 5 min interval from the bottom vessel that was maintained at 378C with constant stirring, and the di¡usion rate was determined by linear regression analysis following 30 min of sampling. The cells were washed twice and 2 ml of medium without glutamate was added to each well. Cells were treated with 200 mmol/L H 2 O 2 for 1 h with or without pretreatment with SB203580 (20 mmol/L) for 20 min before another set of samples was taken. After the second di¡usion rate determination, di¡erences in di¡usion rates before and after treatments were expressed as percent change from the ¢rst value. Three independent experiments were performed.
Immunoprecipitation with HSP27 polyclonal antibody RPAEC cultures were treated with 10 ng/ml LPS (Sigma), 10 ng/ml TNFa (Sigma) or 200 mmol/L H 2 O 2 for 10 min before being washed 26 with PBS and solubilized in 1 ml of immunoprecipitation bu¡er (IPB). IPB contained 50 mmol/L Tris (pH 7.5), 5 mmol/ L ethylenedinitrolo tetraacetic acid, 150 mmol/L NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, and a protease inhibitor cocktail (Complete, Boehringer Mannheim, Indianapolis, IN, USA). After brief centrifugation (5 min at 5000g), lysates were precleared by incubation with 30 ml of protein G-sepharose (Pharmacia) for 30 min followed by centrifugation (2 min at 5000g). Lysates were then incubated with 5 ml of a rabbit polyclonal antibody against rodent HSP27 (Stressgen) for 1 h at 48C. The antibody incubation mixture was then incubated with 30 ml of protein G sepharose for 30 min followed by centrifugation for 2 min at 5000g. The protein G-sepharose pellets were washed 56 with IPB. After washing, the pellets were boiled in 60 ml of SDS sample bu¡er for 5 min and 20 ml of each sample was separated by SDS-PAGE, followed by western blotting using a monoclonal antibody directed against b-actin (Sigma). The same blots were re-probed with a monoclonal antibody directed against HSP27. The ratios of the band density values of b-actin to HSP27 were calculated and normalized to the control sample of each experiment. The experiment was repeated three times.
Statistical analysis
Data from all experimental groups were expressed as mean+SEM. An unpaired students t-test was used to compare di¡erences between control and experimental groups. Statistical signi¢cance was de¢ned as p50.05.
Results
Induction and phosphorylation of HSP27 in LPS treated rats
Northern blot analysis was used to determine if LPS treatment a¡ected steady state HSP27 mRNA levels. We examined heart as well as lung for a comparison because HSP27 is known to be abundant in heart (Lutsch et al., 1997) and heart is more resistant to septic syndrome. HSP27 mRNA was maximally induced by 12 h after LPS injection in heart, while it was only slightly increased in lung ( Figure 1A) . Although there was a robust increase in mRNA in heart after LPS treatment, HSP27 protein levels remained unchanged in both heart and lung and there was no signi¢cant di¡erence at 12 and 24 h compared to control ( Figure 1C ). Phosphorylation status of HSP27 was also determined by IEF followed by Western blotting. The phosphorylation ratio increased signi¢cantly at 3 h after treatment both in heart and lung ( Figure  1B) . The peak increase in phosphorylation was more dramatic in lung than in heart.
Histological and immunohistological ¢ndings in LPS treated lungs
To con¢rm the e¡ect of low dose LPS treatment, the lungs of control and treated rats were examined by H&E staining. By 3 h after injection, macrophage and neutrophil in¢ltra-tion in alveoli was observed, and alveolar walls were thickened in LPS treated lungs ( Figure  2B ) when compared to control lungs treated with PBS (Figure 2A ). To determine which cells expressed HSP27 in lungs, immunohistological staining with anti-HSP27 antibody was performed, and positive staining was observed in capillary endothelial cells in alveoli ( Figure  2C ) and in smooth muscle cells of pulmonary arteries (data not shown). The population of the cells expressing HSP27 in alveoli remained unchanged after LPS injection, as macrophages and neutrophils did not stain for HSP27 ( Figure 2D ). These data suggest that changes in the phosphorylation status of HSP27 in lung is due to the change in the phosphorylation status of HSP27 in capillary endothelial cells of the alveoli and/or in the smooth muscle cells.
E¡ect of anti-TNFa antibody on changes in HSP27 in lung and heart
Because TNFa has been shown to be a key mediator of LPS induced sepsis syndrome (Beutler et al., 1985; Tracey et al., 1987) , we examined the e¡ect of pretreatment with antiTNFa antibody. Anti-TNFa antibody pretreatment appeared to have no e¡ect on HSP27 mRNA induction either in the heart or lung at HSP27 phosphorylation in heart and lung after LPS injection. P/un-p represents the phosphorylation ratio (di-+ mono-/ unphosphorylated form). The right panel shows a portion of a representative IEF Western blot of lung tissues. 0p, 1p, or 2p represent non, mono, di-phosphorylated form of HSP27, respectively. (C) Changes in HSP27 protein levels following LPS infection were determined by SDS PAGE followed by western blotting. White columns (heart) and black columns (lung) represent the relative expression of HSP27 normalized with actin and compared with non-treated lungs (n). The blots used for HSP27 expression were reprobed with antibody against actin to normalize. *p50.05 vs. control. 12 h after LPS injection ( Figure 3A) , while anti-TNFa antibody pretreatment inhibited LPS induced HSP27 phosphorylation at 3 h in both heart and lung ( Figure 3B ). TNFa activity in plasma of the rats used in this series of experiment was measured and no increase was detected in plasma TNFa after LPS injection in antibody-treated rats ( Figure 3C ). Increased HSP27 phosphorylation, which correlated with lung injury, was inhibited by anti-TNFa antibody pretreatment. The same anti-TNFa antibody treatment was reported to inhibit lung injury after LPS injection . Thus, HSP27 phosphorylation in lung at 3 h was dependent on TNFa, and it is likely that the direct causes were factors downstream of TNFa because of the time di¡erence between peaks of HSP27 phosphorylation and TNFa expression.
HSP27 phosphorylation in RPAEC treated with LPS, TNFa, or H 2 O 2
As HSP27 phosphorylation after LPS injection occurs in a manner dependent on TNFa in vivo, the ability of possible modulators to increase phosphorylation of HSP27 in cultured endothelial cells was investigated. H 2 O 2 was used to mimic oxidant injury caused by neutrophils, which starts about 3 h after LPS injection (He£in and Brigham, 1981) . Treatments with LPS, TNFa, and H 2 O 2 caused signi¢cant increases in HSP27 phosphorylation within 30 min ( Figure 4A ). HSP27 phosphorylation at 30 min caused by H 2 O 2 increased in a dose dependent manner ( Figure  4B ). The level of phosphorylation caused by these treatments correlated with earlier observations of endothelial leakage in RPAEC cultures caused by the same treatments (Gilmont et al., 1996) . When cells were pretreated with SB203580 (20 mmol/L), an inhibitor of p38 MAP kinase, phosphorylation of HSP27 was blocked ( Figure 4C ).
Endothelial permeability correlated with HSP27 phosphorylation
Although both LPS and TNFa caused phosphorylation of HSP27 in vivo, they are unlikely to be the direct cause of HSP27 phosphorylation in lung because of the time course considerations. In order to examine the e¡ect of the p38 inhibitor on endothelial leakage, di¡u-sion rates of 70 kDa FITC-dextran across mono-layers of RPAEC were measured with or without H 2 O 2 (200 mmol/L) treatment. Di¡usion rates were increased after treatment with H 2 O 2 and this e¡ect was blocked by pretreatment with SB203580 (20 mmol/L). These data indicate that endothelial leakage caused by H 2 O 2 was dependent on p38 MAP kinase activity, which regulates the phosphorylation HSP27. The increases in permeability correlated with increases in phosphorylation of HSP27.
Actin associated with HSP27
To investigate the e¡ects of phosphorylation on the association of actin and HSP27 in endothelial cells, RPAEC cultures were left untreated or were treated with 10 ng/ml LPS, 10 ng/ml TNFa or 200 mmol/L H 2 O 2 for 1 h prior to being harvested with IP bu¡er. Cell lysates were immunoprecipitated using a polyclonal antibody directed against HSP27. Immunoprecipitated proteins were subjected Figure 3 . The e¡ect of anti-TNFa antibody pre-treatment prior to LPS injection. (A) Anti-TNFa antibody pretreatment had no e¡ect on increased HSP27 mRNA expression at 12 h after LPS injection in either heart (white) or lung (black). (B) Pretreatment with TNFa antibody inhibited increases in HSP27 phosphorylation at 3 h in both heart (white) and lung (black). P/un-p represents the phosphorylation ratio (di-+ mono-/unphosphorylated form). (C) Pretreatment with antiTNFa antibody completely blocked the plasma TNFa activity increase at 1 h after LPS injection. *p50.05 vs. control, # p50.05 vs. LPS only at the same time points. to SDS-PAGE and Western blot analysis. Western blotting was performed using an antib-actin antibody and the same blots were reprobed with a monoclonal anti-HSP27 antibody. Signi¢cantly less b-actin was co-precipitated with HSP27 in cultures treated with LPS or H 2 O 2 ( Figure 5A ), while there is no di¡er-ence in protein expression in cell lysates (Figure 5B) . H 2 O 2 treated cells had the least b-actin associated with HSP27 followed by LPS treatment and TNFa treatment. Thus, there was an i nve r s e re l ati o n sh ip b et we e n HSP 2 7 phosphorylation status and HSP27 association with actin at 1 h post-treatment.
Discussion
In this study, we have demonstrated signi¢-cantly increased HSP27 phosphorylation in the lungs at 3 h after rats were treated with a low dose of LPS. This time-course coincides with the initiation of lung injury after LPS treatment (Koh et al., 1999) . It is generally accepted that the retention of neutrophils or macrophages is responsible for the greatest portion of sepsis induced lung injury in endotoxemia (Worthen et al., 1987) . Granulocyte depletion has been shown to block the large increase in lung permeability after 3 h (He£in and Brigham, 1981) . Kang and colleagues reported that monocytes containing peroxidase-positive granules adhered to endothelial cells at 3 h post treatment (Kang and Williams, 1991) . These observations suggest that by 3 h post treatment leukocytes start to play a major role by producing reactive oxygen species. Because HSP27 phosphorylation was signi¢-cantly increased in the lung by 3 h post LPS injection, HSP27 phosphorylation appears to share the same time course as the initiation of endothelial gap formation in lung injury. HSP27 phosphorylation peaked at 3 h, while lung edema persisted up to 24 h as determined by H&E staining (data not shown). Therefore HSP27 phosphorylation was temporally correlated with the initiation of endothelial gap formation in vivo. Since enhanced HSP27 phosphorylation at 3 h in lung or heart was inhibited by anti-TNFa antibody pretreatment, HSP27 phosphorylation at 3 h was due to direct or indirect e¡ects of TNFa. The mediators of indirect e¡ect of TNFa may be cytokines such as interleukins induced by TNFa, or reactive oxygen species produced by in¢ltrated neutrophils. Anti-TNFa antibody pretreatment has been shown to inhibit lung edema (Seekamp et al., 1993) and neutrophil in¢ltration in the lung after LPS treatment . The reduction in HSP27 phosphorylation seen in this study correlated with the reduction of lung edema caused by anti-TNFa antibody treatment. TNFa has been reported to cause endothelial cell injury and gap formation of cultured endothelial cells when administrated at the same dose used in this study (Goldblum et al., 1993) . In tissue culture, the peak phosphorylation of HSP27 caused by TNFa or LPS occurred at 30 min or 1 h after treatment, respectively. In vivo, HSP27 phosphorylation peaked at 3 h after LPS injection, a full 2 h after the plasma TNFa concentration had peaked. These results imply that the e¡ect of TNFa after LPS treatment on HSP27 phosphorylation in vivo was indirect. TNFa is known to induce cytokines such as interleukin-1 (IL-1), IL-6 and IL-8, and to mediate neutrophil in¢ltration . HSP27 is phosphorylated in response to treatment with IL-1 (Kaur et al., 1989) , TNFa, or H 2 O 2 in cultured cells. In this study, we did not determine the role of other cytokines that can regulate neutrophil in¢ltration. Although it is possible that interleukins directly caused HSP27 phosphorylation in the endothelial cells, it is more likely that oxidant injury caused by neutrophils contributed to phosphorylation as there was neutrophil in¢ltration by 3 h in lung.
Steady state levels of HSP27 mRNA were substantially increased in the heart and only slightly increased in the lung, which did not lead to increased protein expression in either organ. LPS injection caused an increase in HSP27 mRNA of up to 14.5-fold in the heart in this study, which was more dramatic than increases reported for the induction of beta myosin heavy chain (bMHC) mRNA (Macallan and Gri¤n, 1994) . Anti-TNFa antibody had no e¡ect on increases in HSP27 mRNA in this study, or on bMHC mRNA in the heart following LPS injection (Macallan and Gri¤n, 1994) . The minimal induction of HSP27 in lung compared to heart may be due to the di¡erent cell types in both organs and may relate to the severity of tissue insult, as increased expression of HSP27 has been shown to protect cells from damage (Lavoie et al., 1993b) . It is also shown that pretreatment with heat shock decreased LPSinduced acute lung injury of rats (Koh et al., 1999) . In this study, mRNA induction after LPS injection was independent of TNFa or the severity of the injury.
Because we examined phosphorylation of HSP27 using whole tissue, it is likely that the protein is from a mixed cell population. It has been reported that HSP27 mRNA mainly localizes in smooth muscle of arteries in rat lung by in situ hybridization (Wakayama and Isek, 1998) . We observed staining in endothelial cells of alveoli as well as intense staining in smooth muscle cells. Because endothelial cells are the largest cell population in parenchymal tissue followed by interstitial cells (Haies et al., 1981) , we consider endothelial cells to be a major source of HSP27 in the lung.
In the tissue culture model using endothelial cells from pulmonary arteries of rats, increased permeability caused by H 2 O 2 was blocked by pretreatment with the inhibitor of p38 MAP kinase. In these studies, we measured the permeability over a period of 30 min before and after a 1 h treatment with H 2 O 2 . After treatment with 200 mmol/L H 2 O 2 , phosphorylation of HSP27 peaks at 30 min, while endothelial leakage continues to increase over time. This sequence of events appears to be similar to the in vivo observations with LPS treatment. At 60 to 90 min after treatment with H 2 O 2 , 70 kD-dextran leaked through endothelial cell monolayers signi¢cantly more than control, and this process was blocked by inhibition of p38 MAP kinase activity. These data demonstrate that the endothelial leakage caused by H 2 O 2 was regulated by p38 MAP kinase, and is consistent with other studies (Huot et al., 1997; Kevil et al., 2001 ). H 2 O 2 induced phosphorylation of HSP27 was blocked by p38 MAP kinase inhibition as well, and the phosphorylation status of HSP27 correlated with the severity of barrier dysfunction. These results support the possibility that HSP27 is an e¡ecter of p38 MAP kinase.
